Drug waste minimization as an effective strategy of cost-containment in Oncology

by Fasola, Gianpiero, Aprile, Giuseppe, Marini, Luisa, Follador, Alessandro, Mansutti, Mauro, Miscoria, Manuela
Published 2014

Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study

by Mansutti Mauro, Mattioni Laura, Tosolini Marina, Follador Alessandro, Marini Luisa, Aita Marianna, Fasola Gianpiero, Piga Andrea, Brusaferro Silvio, Aprile Giuseppe
Published 2008-04-01

Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study

by Fasola, Gianpiero, Aita, Marianna, Marini, Luisa, Follador, Alessandro, Tosolini, Marina, Mattioni, Laura, Mansutti, Mauro, Piga, Andrea, Brusaferro, Silvio, Aprile, Giuseppe
Published 2008

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

by Bonotto, Marta, Gerratana, Lorenzo, Poletto, Elena, Driol, Pamela, Giangreco, Manuela, Russo, Stefania, Minisini, Alessandro M., Andreetta, Claudia, Mansutti, Mauro, Pisa, Federica E., Fasola, Gianpiero, Puglisi, Fabio
Published 2014

Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID‐19 Pandemic

by Fasola, Gianpiero, Pelizzari, Giacomo, Zara, Diego, Targato, Giada, Petruzzellis, Giuseppe, Minisini, Alessandro Marco, Bin, Alessandra, Donato, Raffaela, Mansutti, Mauro, Comuzzi, Chiara, Candoni, Anna, Sperotto, Alessandra, Fanin, Renato
Published in Oncologist (2021)

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of dif...

by Del Mastro, Lucia, Fabi, Alessandra, Mansutti, Mauro, De Laurentiis, Michele, Durando, Antonio, Merlo, Domenico Franco, Bruzzi, Paolo, La Torre, Ignazia, Ceccarelli, Matteo, Kazeem, Gbenga, Marchi, Paolo, Boy, Davide, Venturini, Marco, De Placido, Sabino, Cognetti, Francesco
Published 2013

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker

by Pelizzari, Giacomo, Basile, Debora, Zago, Silvia, Lisanti, Camilla, Bartoletti, Michele, Bortot, Lucia, Vitale, Maria Grazia, Fanotto, Valentina, Barban, Serena, Cinausero, Marika, Bonotto, Marta, Gerratana, Lorenzo, Mansutti, Mauro, Curcio, Francesco, Fasola, Gianpiero, Minisini, Alessandro Marco, Puglisi, Fabio
Published in Cancers (Basel) (2019)

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

by Basile, Debora, Gerratana, Lorenzo, Corvaja, Carla, Pelizzari, Giacomo, Franceschin, Giorgia, Bertoli, Elisa, Palmero, Lorenza, Zara, Diego, Alberti, Martina, Buriolla, Silvia, Da Ros, Lucia, Bonotto, Marta, Mansutti, Mauro, Spazzapan, Simon, Cinausero, Marika, Minisini, Alessandro Marco, Fasola, Gianpiero, Puglisi, Fabio
Published in Breast (2021)

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant...

by Gianni, Luca, Mansutti, Mauro, Anton, Antonio, Calvo, Lourdes, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chacon, Jose Ignacio, Chan, Arlene, Morales, Serafin, Alvarez, Isabel, Plazaola, Arrate, Zambetti, Milvia, Redfern, Andrew D., Dittrich, Christian, Dent, Rebecca Alexandra, Magazzù, Domenico, De Fato, Raffaella, Valagussa, Pinuccia, Tusquets, Ignacio
Published in JAMA Oncol (2018)